Cell lipid bilayer

The cell lipid bilayer is a fundamental biological structure composed of two layers of amphipathic phospholipids, interspersed with proteins, cholesterol, and carbohydrates. It serves as a semi-permeable barrier that defines the cell boundary, maintains ion gradients, and provides a matrix for membrane-bound signaling proteins. Beyond its structural role, the lipid bilayer is a dynamic platform where the organization of lipids, such as lipid rafts, influences cellular processes like endocytosis and signal transduction. In many diseases, including cancer and neurodegeneration, the composition and fluidity of the membrane are significantly altered, making it a viable target for therapeutic intervention. Therapeutically, the lipid bilayer is a primary target for several classes of anti-infective agents. Antifungal drugs exploit differences in sterol composition (ergosterol vs. cholesterol) to selectively disrupt fungal membranes, while certain antibiotics target the unique anionic lipids of bacterial membranes to induce cell death. Emerging research in membrane lipid therapy aims to treat metabolic and oncological conditions by pharmacologically modifying the membrane's physical properties to correct aberrant signaling. However, the high degree of conservation in membrane structures across species often presents challenges in achieving high therapeutic indices, frequently leading to side effects like nephrotoxicity or hemolysis.

Other names

Biological membranePlasma membranePhospholipid bilayerCell membraneCytoplasmic membrane

Drugs targeting the lipid bilayer typically act through pore formation, membrane depolarization, or physical disruption of the phospholipid arrangement. Polyene antifungals like Amphotericin B bind to membrane sterols (ergosterol) to create lethal trans-membrane channels (StatPearls, 2023). Lipopeptide antibiotics like Daptomycin insert into the bacterial membrane in a calcium-dependent manner, causing rapid depolarization and loss of membrane potential (PubMed, PMID: 15105409). Other agents, such as polymyxins, act as surfactants that interact with lipopolysaccharides to disrupt the integrity of the outer and inner membranes of Gram-negative bacteria (NIH, 2022). Additionally, membrane lipid therapy (MLT) involves modulating the membrane's biophysical properties or lipid composition to regulate signaling pathways (Journal of Cell Biology, 2017).